LeMaitre Vascular, Inc. (LMAT)
| Market Cap | 1.21B |
| Revenue (ttm) | 150.52M |
| Net Income (ttm) | 28.77M |
| Shares Out | 20.61M |
| EPS (ttm) | 1.39 |
| PE Ratio | 40.12 |
| Forward PE | 36.90 |
| Dividend | $0.41 (0.74%) |
| Ex-Dividend Date | Aug 25, 2021 |
| Volume | 190,217 |
| Open | 55.52 |
| Previous Close | 55.74 |
| Day's Range | 54.93 - 55.96 |
| 52-Week Range | 30.93 - 64.37 |
| Beta | 1.32 |
| Analysts | Buy |
| Price Target | 66.14 (+18.7%) |
| Est. Earnings Date | Oct 28, 2021 |
About LMAT
LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. It offers angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that temporarily occlude the blood flow; perfusion catheters to perfuse the blood and other fluids into the vasculature; and thrombectomy catheters, which features a silicone balloon for removing thrombi in the ...
Financial Performance
In 2020, LMAT's revenue was $129.37 million, an increase of 10.35% compared to the previous year's $117.23 million. Earnings were $21.22 million, an increase of 18.32%.
Financial StatementsAnalyst Forecast
According to 5 analysts, the average rating for LMAT stock is "Buy." The 12-month stock price forecast is 66.14, which is an increase of 18.70% from the latest price.
News
LeMaitre Vascular to Participate at Upcoming Investor Conferences in September
BURLINGTON, Mass., Sept. 01, 2021 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will be participating in four virtual investor conferences in September.
LeMaitre to Present at Upcoming Investor Conferences
BURLINGTON, Mass., Aug. 06, 2021 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it is participating in two investor conferences in August.
Is This Under-the-Radar Medical Device Company a Post-Earnings Buy?
LeMaitre Vascular's operating fundamentals and balance sheet suggest it's a buy, depending on your objectives.
LeMaitre Vascular (LMAT) Beats Q2 Earnings Estimates
LeMaitre (LMAT) delivered earnings and revenue surprises of 17.65% and -0.07%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
LeMaitre Q2 2021 Financial Results
BURLINGTON, Mass., July 29, 2021 (GLOBE NEWSWIRE) -- LeMaitre (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q2 2021 results, announced an $0.11/share quarterly div...
Is LeMaitre (LMAT) a Solid Growth Stock? 3 Reasons to Think " Yes "
LeMaitre (LMAT) possesses solid growth attributes, which could help it handily outperform the market.
LeMaitre Will Announce Second Quarter 2021 Earnings Results on July 29, 2021
BURLINGTON, Mass., July 15, 2021 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its second quarter 2021 financial results on Thursday, July 29, 2021, afte...
LeMaitre Vascular (LMAT) to Report Q2 Results: Wall Street Expects Earnings Growth
LeMaitre (LMAT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
LeMaitre Vascular Sees Better Than Expected Q2 Sales, Raises $55M Via Equity At 9% Discount
LeMaitre Vascular Inc (NASDAQ: LMAT) has announced preliminary Q2 2021 results and sees net sales of $40.7 million compared to an estimated $37.9 million, up 64%Y/Y on a reported basis and +35% organica...
LeMaitre Announces Pricing of Public Offering of Common Stock
BURLINGTON, Mass., July 13, 2021 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of peripheral vascular devices, implants and services, today announced the pricing of an underwritt...
LeMaitre Vascular Announces Proposed Public Offering of Common Stock
BURLINGTON, Mass., July 13, 2021 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of peripheral vascular devices, implants and services, today announced that it has commenced an und...
LeMaitre Provides Q2 2021 Update
BURLINGTON, Mass., July 13, 2021 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of peripheral vascular devices, implants and services, today announced preliminary unaudited result...
Should Investors Consider This Expanding Healthcare Business After Its Massive Dividend Hike?
Did LeMaitre Vascular jeopardize its payout with its recent 16% dividend lift?
LeMaitre to Present at the Goldman Sachs Virtual Global Healthcare Conference
BURLINGTON, Mass., June 09, 2021 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that David Roberts, President, will present at the Goldman Sachs 42nd Annual Virtual Global Hea...
LeMaitre Regains Five CE Marks
BURLINGTON, Mass., May 25, 2021 (GLOBE NEWSWIRE) -- LeMaitre (Nasdaq:LMAT), a provider of vascular devices, implants and services, today announced that it received CE marks under the European Medical De...
LeMaitre to Present at the Jefferies Virtual Healthcare Conference
BURLINGTON, Mass., May 20, 2021 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that JJ Pellegrino, Chief Financial Officer, will present at the Jefferies Virtual Healthcare Co...
LeMaitre Vascular (LMAT) Recently Broke Out Above the 20-Day Moving Average
Should investors be excited or worried when a stock crosses above the 20-day simple moving average?
LeMaitre Vascular (LMAT) Matches Q1 Earnings Estimates
LeMaitre (LMAT) delivered earnings and revenue surprises of 0.00% and 0.95%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Recap: LeMaitre Vascular Q1 Earnings
Shares of LeMaitre Vascular (NASDAQ:LMAT) were flat in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share rose 75.00% over the past year to $0.28, which bea...
LeMaitre Q1 2021 Financial Results
BURLINGTON, Mass., April 29, 2021 (GLOBE NEWSWIRE) -- LeMaitre (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q1 2021 results and announced an $0.11/share quarterly...
LeMaitre to Present at Upcoming Investor Conferences
BURLINGTON, Mass., April 27, 2021 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it is participating in two investor conferences in May.
Bull Of The Day: LeMatire Vascular (LMAT)
Bull Of The Day: LeMatire Vascular (LMAT)
LeMaitre Vascular (LMAT) Earnings Expected to Grow: Should You Buy?
LeMaitre (LMAT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
LeMaitre Will Announce First Quarter 2021 Earnings Results on April 29, 2021
BURLINGTON, Mass., April 14, 2021 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its first quarter 2021 financial results on Thursday, April 29, 2021, aft...
4 Critical Care Device Stocks to Deflect the COVID-19 Curveball
Cantel (CMD), Hill-Rom (HRC), LeMaitre (LMAT) and Masimo (MASI) can prove to be prudent investment choices in the critical care industry of the MedTech sector.